The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

Obesity, a new report recommends, should be diagnosed by an individual’s body fat percentage, not weight, which was the norm ...

A Personal View published in The Lancet Oncology challenges the long-standing perception of metastatic brain cancer, calling ...

High blood pressure is one of the world’s leading causes of death, yet many people struggle to keep it under control. A new ...

Studies have shown that specific gene variations make women more susceptible to lung cancer, even without smoking.

The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into ...

When Aletah Whitman's leg suddenly jolted her awake at 3 a.m. on Nov. 12, 2023, she had no idea it was the first sign of a ...

Lancet Commission chair Eliah Aronoff-Spencer (front) of UC San Diego attends the UN Science Summit in the fall of 2024 with Lancet Commission co-chairs Richard Carpiano (center back) of UC Riverside ...

Statins help people manage high cholesterol levels, but many experts want to know if these drugs can also support brain ...

The commission’s leadership includes Richard Carpiano, Ph.D., M.P.H., professor of public policy at the University of ...

With a healthy BMI, a good diet and healthy habits, Gail had an unlikely profile for a heart attack - which meant she was not ...